Vaccine Purchasers Accuse Sanofi Of Stifling Competition

Law360, New York (December 12, 2011, 3:20 PM EST) -- Sanofi Pasteur Inc. was hit on Friday in New Jersey federal court with a putative class action accusing the vaccine powerhouse of imposing anti-competitive contract restrictions on its customers that prevent them from seeking vaccines from Sanofi rivals.

According to the suit, Sanofi enforces contracts with physicians and other customers that dramatically raise the price of meningococcal vaccines used to combat meningitis, as well as the company's other vaccines, if the physicians seek alternate remedies from Sanofi competitors.

“Sanofi has maintained its dominance in the market...
To view the full article, register now.